Published in Sleep on February 01, 2008
Diminished capability to recognize the optimal temperature for sleep initiation may contribute to poor sleep in elderly people. Sleep (2008) 1.01
Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat (2008) 0.96
Sleep, vigilance, and thermosensitivity. Pflugers Arch (2011) 0.95
Cold hands, warm feet: sleep deprivation disrupts thermoregulation and its association with vigilance. Sleep (2012) 0.83
Dysautonomia in narcolepsy: evidence by questionnaire assessment. J Clin Neurol (2014) 0.76
Increased skin temperature in Alzheimer's disease is associated with sleepiness. J Neural Transm (Vienna) (2012) 0.76
Time to wake up: reactive countermeasures to sleep inertia. Ind Health (2016) 0.75
Core Body and Skin Temperature in Type 1 Narcolepsy in Daily Life; Effects of Sodium Oxybate and Prediction of Sleep Attacks. Sleep (2016) 0.75
Current and Future Treatment Options for Narcolepsy: A Review. Sleep Sci (2017) 0.75
Orexins and the cardiovascular events of awakening. Temperature (Austin) (2017) 0.75
Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50
Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. Am J Physiol (1999) 2.60
Relationship between alertness, performance, and body temperature in humans. Am J Physiol Regul Integr Comp Physiol (2002) 2.15
Effects of hot and cold temperature exposure on performance: a meta-analytic review. Ergonomics (2002) 1.89
EEG and ocular correlates of circadian melatonin phase and human performance decrements during sleep loss. Am J Physiol (1999) 1.83
Circadian rhythm of heat production, heart rate, and skin and core temperature under unmasking conditions in men. Am J Physiol (1994) 1.67
Adaptation to abrupt time shifts of the oscillator(s) controlling human circadian rhythms. J Physiol (1978) 1.56
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol (2001) 1.56
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology (2000) 1.47
The validity of psychomotor vigilance tasks of less than 10-minute duration. Behav Res Methods Instrum Comput (2004) 1.44
Warm feet promote the rapid onset of sleep. Nature (1999) 1.38
Body temperature and performance under different routines. J Appl Physiol (1950) 1.21
Mechanisms and functions of coupling between sleep and temperature rhythms. Prog Brain Res (2006) 1.17
Circadian rhythms in human performance and mood under constant conditions. J Sleep Res (1997) 1.12
Cutaneous warming promotes sleep onset. Am J Physiol Regul Integr Comp Physiol (2005) 1.06
Altered skin-temperature regulation in narcolepsy relates to sleep propensity. Sleep (2006) 1.05
Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep (2006) 1.04
The influence of subjective alertness and motivation on human performance independent of circadian and homeostatic regulation. J Biol Rhythms (2003) 0.96
Sleepiness as measured by modified multiple sleep latency testing varies as a function of preceding activity. Sleep (1998) 0.96
Time-on-task impairment of psychomotor vigilance is affected by mild skin warming and changes with aging and insomnia. Sleep (2007) 0.94
Circadian rhythm of temperature in man. Comparative study with two experiment protocols. Chronobiologia (1981) 0.80
Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. Electroencephalogr Clin Neurophysiol (1998) 0.79
Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls. Rev Electroencephalogr Neurophysiol Clin (1981) 0.78
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol (2002) 4.03
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
A survey of tools for variant analysis of next-generation genome sequencing data. Brief Bioinform (2013) 3.60
Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace (2004) 2.47
Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry (2011) 2.45
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA (2008) 2.07
Fragmentation and stability of circadian activity rhythms predict mortality: the Rotterdam study. Am J Epidemiol (2014) 2.05
Sleep benefits subsequent hippocampal functioning. Nat Neurosci (2009) 2.05
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial. Lancet Neurol (2009) 2.01
Hypocretin (orexin) loss in Parkinson's disease. Brain (2007) 1.98
A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab (2010) 1.98
Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke (2006) 1.93
Startle syndromes. Lancet Neurol (2006) 1.93
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
The "posture second" strategy: a review of wrong priorities in Parkinson's disease. J Neurol Sci (2006) 1.78
Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain (2010) 1.76
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol (2013) 1.71
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet (2010) 1.67
Integrated multidisciplinary care in Parkinson's disease: a non-randomised, controlled trial (IMPACT). Lancet Neurol (2013) 1.60
Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Proc Natl Acad Sci U S A (2009) 1.59
Reduced orbitofrontal and parietal gray matter in chronic insomnia: a voxel-based morphometric study. Biol Psychiatry (2010) 1.58
Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial. BMJ (2013) 1.57
Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology (2011) 1.56
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. Mov Disord (2012) 1.54
Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav (2002) 1.53
Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis. Clin Neurophysiol (2012) 1.52
Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'? Sleep Med (2002) 1.51
Natural history of obstetric brachial plexus palsy: a systematic review. Dev Med Child Neurol (2004) 1.46
Hypocretin/orexin disturbances in neurological disorders. Sleep Med Rev (2008) 1.45
Evaluation of wireless determination of skin temperature using iButtons. Physiol Behav (2006) 1.44
Intraoperative nerve action and compound motor action potential recordings in patients with obstetric brachial plexus lesions. J Neurosurg (2008) 1.43
Extensive motor axonal misrouting after conservative treatment of obstetric brachial plexus lesions. Dev Med Child Neurol (2014) 1.41
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res (2009) 1.37
Skin deep: enhanced sleep depth by cutaneous temperature manipulation. Brain (2008) 1.34
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry (2007) 1.29
Prefrontal hypoactivation and recovery in insomnia. Sleep (2008) 1.28
The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J Immunol (2007) 1.28
Narcolepsy: immunological aspects. Sleep Med Rev (2008) 1.28
Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain (2009) 1.27
Sleep loss affects vigilance: effects of chronic insomnia and sleep therapy. J Sleep Res (2008) 1.27
Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve (2010) 1.24
The role of environmental light in sleep and health: effects of ocular aging and cataract surgery. Sleep Med Rev (2010) 1.22
Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc (2007) 1.22
Sleep, cognition, and behavioral problems in school-age children: a century of research meta-analyzed. Psychol Bull (2012) 1.21
Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol (2011) 1.21
Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21
Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry (2007) 1.21
Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome. Am J Hum Genet (2012) 1.21
Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res (2003) 1.19
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Expectancy induces dynamic modulation of corticospinal excitability. J Cogn Neurosci (2007) 1.17
Corticospinal beta-band synchronization entails rhythmic gain modulation. J Neurosci (2010) 1.17
Beauty sleep: experimental study on the perceived health and attractiveness of sleep deprived people. BMJ (2010) 1.15
iLAP: a workflow-driven software for experimental protocol development, data acquisition and analysis. BMC Bioinformatics (2009) 1.14
Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care (2010) 1.14
Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr (2005) 1.14
Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol (2002) 1.11
Circadian and age-related modulation of thermoreception and temperature regulation: mechanisms and functional implications. Ageing Res Rev (2002) 1.10
Orbitofrontal gray matter relates to early morning awakening: a neural correlate of insomnia complaints? Front Neurol (2012) 1.09
Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain (2005) 1.08
The ParkinsonNet concept: development, implementation and initial experience. Mov Disord (2010) 1.08
Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2011) 1.07
The relationship between insomnia and body temperatures. Sleep Med Rev (2008) 1.07
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res (2013) 1.07
Non-pharmacological interventions in cognitively impaired and demented patients--a comparison with cholinesterase inhibitors. Rev Neurosci (2003) 1.07
Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry (2009) 1.06
Cutaneous warming promotes sleep onset. Am J Physiol Regul Integr Comp Physiol (2005) 1.06
Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging (2011) 1.05
Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry (2010) 1.05
Altered skin-temperature regulation in narcolepsy relates to sleep propensity. Sleep (2006) 1.05
The inferior frontal cortex in artificial syntax processing: an rTMS study. Brain Res (2008) 1.04
Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep (2006) 1.04
Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. J Neurol Neurosurg Psychiatry (2010) 1.03
The Amsterdam Resting-State Questionnaire reveals multiple phenotypes of resting-state cognition. Front Hum Neurosci (2013) 1.03
Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiology (2004) 1.02
Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin. Ageing Res Rev (2012) 1.01
The role of personality traits in insomnia. Sleep Med Rev (2009) 1.01
Diminished capability to recognize the optimal temperature for sleep initiation may contribute to poor sleep in elderly people. Sleep (2008) 1.01
Physical inactivity in Parkinson's disease. J Neurol (2011) 1.00
Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab (2011) 0.99
The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med (2010) 0.99
Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy. J Clin Sleep Med (2008) 0.99